Crossmark

CHAARTED/GETUG 12—docetaxel in non-castrate prostate cancers

Crossref DOI link: https://doi.org/10.1038/nrclinonc.2015.192

Published Online: 2015-11-10

Published Print: 2015-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Teo, Min Yuen

Scher, Howard I.
License Information

Text and Data Mining valid from 2015-11-10
More Information

Article History

First Online: 10 November 2015

Competing interests

: H.I.S. has received reimbursement of travel and has acted as a consultant (noncompensated) for Sanofi. M.Y.T. declares no competing interests.